Molecular mechanisms of nitric oxide-induced growth arrest and apoptosis in fetal pulmonary arterial smooth muscle cells

Nitric Oxide - Biology and Chemistry

Volumn 9, Issue 4, 2003, Pages 201-210

  Wedgwood, Stephen ^a   Black, Stephen M ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

Apoptosis; G0 G1 growth arrest; Nitric oxide; Superoxide; Vascular smooth muscle

Indexed keywords

CASPASE; CYCLIN A; DNA FRAGMENT; NITRIC OXIDE; NITRIC OXIDE DONOR; PEROXYNITRITE; PROTEIN P21; PROTEIN P27; SPERMINE; SUPEROXIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; FETUS; FLUORESCENCE MICROSCOPY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOLECULAR MECHANICS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PULMONARY ARTERY; SHEEP; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CASPASES; CELL CYCLE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FETUS; HUMANS; INFANT, NEWBORN; MEMBRANE POTENTIALS; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGEN OXIDES; PERSISTENT FETAL CIRCULATION SYNDROME; PULMONARY ARTERY; SHEEP; SPERMINE; SUPEROXIDES;

OVIS ARIES;

EID: 1442299824     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2003.11.005     Document Type: Article

References (47)

1. Steinhorn R.H., Millard S.L., Morin III F. Persistent pulmonary hypertension of the newborn: role of nitric oxide and endothelin in pathophysiology and treatment. Clin. Perinatol. 22:1995;405-428.
2. Haworth S., Reid L. Persistent fetal circulation: newly recognized structural features. J. Pediatr. 88:1976;614-620.
3. Mecham R., Whitehouse L., Wren D., Parks W., Griffin G., Senior R., Crouch E., Vœlkel N., Stenmark K. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science. 237:1987;423-426.
4. Abman S.H., Shanley P.F., Accurso F.J. Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J. Clin. Invest. 83:1989;1849-1858.
5. Black S.M., Johengen M.J., Soifer S.J. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs. Pediatr. Res. 44:1998;821-830.
6. Morin III F.C. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr. Res. 25:1989;245-250.
7. Wild L.M., Nickerson P.A., Morin III F.C. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr. Res. 25:1989;251-257.
8. Tanner F.C., Meier P., Greutert H., Champion C., Nabel E.G., Luscher T.F. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation. 101:2000;1982-1989.
9. Ignarro L.J., Buga G.M., Wei L.H., Bauer P.M., Wu G., del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. USA. 98:2001;4202-4208.
10. Pegg A.E., Shantz L.M., Coleman C.S. Ornithine decarboxylase as a target for chemoprevention. J. Cell Biochem. 22:1995;132-138.
11. Lau H. Cytotoxicity of nitric oxide donors in smooth muscle cells is dependent on phenotype, and mainly due to apoptosis. Atherosclerosis. 166:2003;223-232.
12. Wedgwood S., Dettman R.W., Black S.M. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am. J. Physiol. 281:2001;L1058-L1067.
13. Cory A.H., Owen T.C., Barltrop J.A., Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3:1991;207-212.
14. Wedgwood S., Mitchell C.J., Fineman J.R., Black S.M. Developmental differences in the shear stress-induced expression of endothelial NO synthase: changing role of AP-1. Am. J. Physiol. 284:2003;L650-L662.
15. ′ -tetraethylbenzimidazolcarbocyanine iodide (JC-1) Biochem. Biophys. Res. Commun. 197:1993;40-45.
16. Boise L.H., Thompson C.B. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA. 94:1997;3759-3764.
17. Cohen J.J., Duke R.C., Fadok V.A., Sellins K.S. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:1992;267-293.
18. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:1992;961-971.
19. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
20. Ross R. A pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
21. Rao G., Berk B. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 18:1992;775-794.
22. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
23. Tsai J., Jain M., Hsieh C., Lee W., Yoshizumi M., Patterson C., Perralla M., Cook C., Wang H., Haber E., Schlegal R., Lee M. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J. Biol. Chem. 271:1996;3667-3670.
24. Brown M., Miller F., Li W., Ellingson A., Mozena J., Chatterjee P., Engelhardt J., Zwacka R., Oberley L., Fang X., Spector A., Weintraub N. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ. Res. 85:1999;524-533.
25. Grunfeld S., Hamilton C.A., Mesaros S., McClain S.W., Dominiczak A.F., Bohr D.F., Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 26:1995;854-857.
26. Langenstroer P., Pieper G. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am. J. Physiol. 263:1992;H257-H265.
27. Ohara Y., Peterson T., Harrison D. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91:1993;2546-2551.
28. Brennan L.A., Steinhorn R.H., Wedgwood S., Mata-Greenwood E., Roark E.A., Russell J.A., Black S.M. Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ. Res. 92:2003;683-691.
29. Boulanger C., Luscher T.F. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85:1990;587-590.
30. Redmond E.M., Cahill P.A., Hodges R., Zhang S., Sitzmann J.V. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells. J. Cell Physiol. 166:1996;469-479.
31. Ciarallo S., Subramaniam V., Hung W., Lee J.H., Kotchetkov R., Sandhu C., Milic A., Slingerland J.M. Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest. Mol. Cell. Biol. 22:2002;2993-3002.
32. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 9:1996;836-844.
33. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356:1998;1-11.
34. Susin S.A., Daugas E., Ravagnan L., Samejima K., Zamzami N., Loeffler M., Costantini P., Ferri K.F., Irinopoulou T., Prevost M.C., Brothers G., Mak T.W., Penninger J., Earnshaw W.C., Kroemer G. Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192:2000;571-580.
35. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405-413.
36. Rinkenberger J.L., Korsmeyer S.J. Errors of homeostasis and deregulated apoptosis. Curr. Opin. Genet. Dev. 7:1997;589-596.
37. Kuida K., Haydar T.F., Kuan C.Y., Gu Y., Taya C., Karasuyama H., Su M.S., Rakic P., Flavell R.A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:1998;325-337.
38. Atz A.M., Wessel D.L. Inhaled nitric oxide in the neonate with cardiac disease. Semin. Perinatol. 21:1997;441-455.
39. Roberts J.D. Jr., Fineman J.R., Morin III F.C., Shaul P.W., Rimar S., Schreiber M.D., Polin R.A., Zwass M.S., Zayek M.M., Gross I., Heymann M.A., Zapol W.M. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The inhaled nitric oxide study group. N. Engl. J. Med. 336:1997;605-610.
40. Rossaint R., Falke K.J., Lopez F., Slama K., Pison U., Zapol W.M. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:1993;399-405.
41. Markewitz B.A., Michael J.R. Inhaled nitric oxide in adults with the acute respiratory distress syndrome. Respir. Med. 94:2000;1023-1028.
42. Atz A., Adatia I., Wessel D. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann. Thorac. Surg. 62:1996;1759-1764.
43. Cueto E., Lopez-Herce J., Sanchez A., Carrillo A. Life-threatening effects of discontinuing inhaled nitric oxide in children. Acta Paediatr. 86:1997;1337-1339.
44. Lavoie A., Hall J.B., Olson D.M., Wylam M.E. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am. J. Respir. Crit. Care Med. 153:1996;1985-1987.
45. Miller O.I., Tang S.F., Keech A., Celermajer D.S. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet. 346:1995;51-52.
46. Wedgwood S., McMullan D.M., Bekker J.M., Fineman J.R., Black S.M. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ. Res. 89:2001;357-364.
47. Steinhorn R.H., Albert G., Swartz D.D., Russell J.A., Levine C.R., Davis J.M. Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. Am. J. Respir. Crit. Care Med. 164:2001;834-839.